Easy you better hope we don't have to wait until Europe approval for a deal or sale. If they sell another 20% of the company at an all time low stock, the destructive impact to our interests would be irreversible IMO. It's a death spiral. I trust they will do what's in the best interests for the company's owners and patients. If they wanted to keep screwing shareholders, they would have left O'Connor in place.
Market Data 
Markets 
AI
